ITGB1 and neoplasm: Thus, the results from Li et al. (35) combined with our study suggest that the ANG-2–mediated ITGB1-dependent mechanism likely dominates in the tumor progression setting and the ANG-2–mediated TIE-2–dependent mechanism in an autoimmune setting.